Plasma treatment for sudden liver failure
Part of Digestive system, Infections clinical trials.
This study tests a treatment that cleans your blood to help your liver recover if you have sudden liver failure. It may improve your chances of getting better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sudden liver failure from any cause
- Your body shows signs of inflammation (like fever or fast heart rate)
- Your liver failure is at least grade 2 on a standard scale
- You are not eligible for steroid treatment for alcohol-related liver disease
- You do not have other serious conditions like cancer, severe heart or lung disease, or kidney failure
- You are not pregnant and can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure that cleans your blood (called plasma exchange) given at half the usual dose, along with other detox methods, to help people with sudden liver failure. It aims to help your liver recover or support you while you wait for a transplant.
This trial tests whether giving a smaller amount of a blood-cleaning treatment (plasma exchange) can help people with sudden liver failure on top of long-term liver disease. It aims to improve liver function and overall outcomes.
This trial tests a new liver dialysis device called DIALIVE 2.0 for people with acute-on-chronic liver failure (a sudden, severe worsening of chronic liver disease). If you qualify, the device will help filter your blood, similar to kidney dialysis, to support your liver while it tries to recover.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
This study tests whether a treatment made from stem cells (cells that can help repair tissues) can improve liver function in people with a sudden worsening of long-term liver disease. The stem cells are given through a vein, and the goal is to see if they help the liver recover without needing a transplant.
This trial tests whether a treatment called plasma exchange (which removes harmful substances from your blood and replaces them with healthy plasma) can help improve the function of other organs, like the kidneys or lungs, in people with advanced liver failure. It aims to find out if this treatment helps you recover better and to identify markers that show if the treatment is working.
Hear when a new Acute-on-Chronic Liver Failure (ACLF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.